Kassner, U; Hollstein, T; Schumann, F; Grenkowitz, T; Scharnagl, H; Marz, W; Steinhagen-Thiessen, E.
PROPROTEIN CONVERTASE SUBTILISIN/ KEXIN TYPE 9 ANTIBODIES (PCSK9-I) TREATMENT OF CARDIOVASCULAR HIGH RISK PATIENTS IN CLINICAL PRACTICE
ATHEROSCLEROSIS. 2019; 287: E212-E212.-87th Congress of the European-Atherosclerosis-Society (EAS); MAY 26-29, 2019; Maastricht, NETHERLANDS.
Doi: 10.1016/j.atherosclerosis.2019.06.645
[Poster]
Web of Science
FullText
FullText_MUG